FDA clears AtriCure's heart device

06/14/2010 | MedCityNews.com

AtriCure has received 510(k) clearance from the FDA for its AtriClip Gillinov-Cosgrove Left Atrial Appendage Exclusion System, which prevents blood clots during cardiac procedures. The company plans a full launch of the product this year.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX